Methods for screening for substances which inhibit FP prostanoid receptor interaction with a compound having PGF2alphaalphaactivity and methods of treating cancer

Details for Australian Patent Application No. 2002248322 (hide)

Owner The Arizona Board of Regents, on behalf of, The University of Arizona

Inventors Regan, John, W.

Agent Pizzeys

Pub. Number AU-B-2002248322

PCT Pub. Number WO2002/058546

Priority 60/263,503 24.01.01 US

Filing date 24 January 2002

Wipo publication date 6 August 2002

Acceptance publication date 9 June 2005

International Classifications

G01N 033/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

6 February 2003 Application Open to Public Inspection

  Published as AU-B-2002248322

9 June 2005 Application Accepted

  Published as AU-B-2002248322

6 October 2005 Standard Patent Sealed

13 September 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002248323-STABLE ISOTOPE, SITE-SPECIFIC MASS TAGGING FOR PROTEIN IDENTIFICATION

2002248321-SUBSTITUTED INDOLINES AS 5-HT RECEPTOR LIGANDS